| Identification | Back Directory | [Name]
(4aR,4bS,6aR,7R,9aS,9bS,10S,11aR)-7-[(1R)-1,5-Dimethylhexyl]hexadecahydro-1,4a,6a,10-tetramethyl-2H-indeno[5,4-f]quinolin-2-one | [CAS]
158493-17-5 | [Synonyms]
(4aR,4bS,6aR,7R,9aS,9bS,10S,11aR)-7-[(1R)-1,5-Dimethylhexyl]hexadecahydro-1,4a,6a,10-tetramethyl-2H-indeno[5,4-f]quinolin-2-one | [Molecular Formula]
C28H49NO | [MDL Number]
MFCD00931655 | [MOL File]
158493-17-5.mol | [Molecular Weight]
415.69 |
| Hazard Information | Back Directory | [Uses]
MK 386 acts as a selective human type 1 5α-reductase inhibitor which may be used in the treatment of male pattern baldness. Also may be used to instigate androgen deprivation in the treatment of disseminated prostate cancer. | [storage]
Store at -20°C |
|
|